Medicinal Chemistry Research

, Volume 27, Issue 5, pp 1538–1548 | Cite as

Evidences for the antitumor potentiality of Hemimycale arabica and Negombata magnifica mesohyls in hepatocellular carcinoma rat model

  • Hanaa H. Ahmed
  • Hanaa M. Rady
  • Soheir E. Kotob
Original Research
  • 18 Downloads

Abstract

The current study was constructed to explore the antitumor activity of Hemimycale arabica (blue sponge) and Negombata magnifica (red sponge) mesohyls in rat model of HCC. Forty adult female albino rats were distributed into: (1) negative control group, (2) HCC group, (3) Doxorubcin (DOXO)-treated group, (4) mesohyl of H. arabica-treated group, and (5) mesohyl of N. magnifica-treated group. Serum AST, ALT, GGT, α-fucosidase (AFU) activities; bilirubin, AFP and CEA levels was evaluated. Histopathological investigation of liver tissue sections was performed. The findings of this study indicated the presence of significant enhancement in serum AST, ALT, GGT, AFU, bilirubin, AFP, and CEA values in HCC-afflicted rats vs. the control counterparts. Insignificant change in serum AST, ALT, and GGT activity as well as bilirubin levels has been detected upon treatment of HCC-afflicted rats with DOXO. DOXO treatment revealed significant depletion in AFU, CEA, and AFP serum values comparing with HCC-afflicted ones. Treatment of HCC-afflicted rats with mesohyl blue (Hemimycale arabica) or red (Negombata magnifica) sponges evoked significant blunting in the measured biochemical parameters with respect to the untreated HCC-afflicted ones. The favorable impact of the natural treatments was documented by the great recovery of the structural organization of the liver of the treated rats. The current study provides an experimental evidence for the antitumor potential of Hemimycale arabica and Negombata magnifyica mesohyls in HCC rat model which may be ascribed to the strong hepatoprotective activity, the powerful free radical scavenging ability, and the highly apoptotic property of their active constitutes.

Keywords

Hepatocellular carcinoma Hemimycale arabica Negombata magnifica Mesohyl Rat 

Notes

Acknowledgements

The authors appreciate the project No. 10160003 entitled (Preclinical Evaluation of Anticancer Efficacy and Pharmacological Properties of Promising Marine Sponge—Derived Anticancer Agents) funded from the National Research Centre, Egypt, for its kind support and effort in performing this manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Abbas AT, El-Shitany NA, Shaala LA, Ali SS, Azhar EI, Abdel-Dayem UA, Youssef DTA (2014) Red Sea Suberea mollis sponge extract protects against CCl4-induced acute liver injury in rats via an antioxidant mechanism. Evid Based Complement Altern Med 2014:Article ID 745606:9Google Scholar
  2. Abdallah IZ, Khattab HA (2004) Protective role of lycopene against diethylnitrosamine induced experimental hepatocarcinogenesis. Egypt J Hosp Med 16:1–13Google Scholar
  3. Abd-Rabou AA, Zoheir KM, Ahmed HA (2012) Potential impact of curcumin and taurine on human hepatoma cells using Huh-7 cell line. Clin Biochem 45:1519–1521CrossRefPubMedGoogle Scholar
  4. Adreana M, Suciu S, Clichici S, Daicoviciu D, Pop N, Postescu I (2006) Study on the effects of grape seed extract in ehrlich ascetic carcinoma. Bul USAMV CN 63:114–119Google Scholar
  5. Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41:40–59CrossRefPubMedGoogle Scholar
  6. Ahmed HH, Shousha WG, El-Mezayen HA, El-Toumy SA, Ramadan AR (2015) Updates on the biochemical and molecular mechanisms of N-nitrosodiethylamine-induced hepatocellular carcinoma: promising therapeutic role of Punica granatum peel extract. Int J Pharm Sci Rev Res 32(2):121–144Google Scholar
  7. Ajani JA (2008) Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen. Cancer 113:945–955CrossRefPubMedGoogle Scholar
  8. Aleem E, Elshayeb A, Elhabachi N, Mansour AR, Gowily A, Hela A (2012) Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncol Lett 3(3):704–712CrossRefPubMedGoogle Scholar
  9. Andreev AV, Grigor’eva EIu, GusevAI (1993) Analytical characteristics of commercial IRMA-AFP kit for determination of human alpha-fetoprotein. Klin Lab Diagn 1(3):54–58Google Scholar
  10. Armitage P, Berry G (1987) Comparison of several groups. In: Blockwell Significant Publication editorial office, London (ed) Statistical method in medical research, 2nd edn. Blockwell Significant Publication, Oxford, pp 186–213Google Scholar
  11. Avilés A, Herrera J, Ramos E (1984) Hepatic injury during doxorubicin therapy. Arch Patho Lab Med 108(11):912–913Google Scholar
  12. Baig JA, Alam JM, Mahmood SR, Baig M, Shabeen R, Sultana I, Waheed A (2009) Hepptocellular carcinoma (HCC) and diagnostic significance of alpha-fetoprotein (AFP). J Ayub Med Coll Abbottabad 21:72–75PubMedGoogle Scholar
  13. Balamurugan K (2011) Molecular investigation on the efficacy of luteolin as a potent therapeutic agent for experimentally induced hepatocellular carcinoma in wistar albino rats. Ph.D. Thesis, University of Prist, Vallam, ThanjavurGoogle Scholar
  14. Banchroft JD, Stevens A, Turner DR (1996) Theory and practice of histological techniques, 4th edn. Churchill Livingstone, New York, London, San Francisco, TokyoGoogle Scholar
  15. Barnes JM, Paget GE (1965) Mechanisms of toxic action. Prog Med Chem 4:18–38CrossRefPubMedGoogle Scholar
  16. Begent RHJ, Keep PA, Searle F, Green AJ, Mitchell HDC, Jones BE, Dent J, Pendower JEH, Parkins RA, Reynolds KW, Cooke TG, Mersh TA, Bagshawe KD (1986) Radioimmunolocalization and selection for surgery in recurrent colorectal cancer. Br J Surg Soc Ltd 73(1):64–67CrossRefGoogle Scholar
  17. Bukofzer S, Stass PM, Kew MC, de Beer M, Groeneveld HT (1989) Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks. Br J Cancer 59:417–420CrossRefPubMedPubMedCentralGoogle Scholar
  18. Cao J, Jiang L, Zhang X, Yao X, Geng C, Xue X, Zhong L (2008) Boric acid inhibits LPS-induced TNF-alpha formation through a thiol-dependent mechanism in THP-1 cells. J Trace Elem Med Biol 22:189–195CrossRefPubMedGoogle Scholar
  19. Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F (2014) Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype, for the Italian Liver Cancer (ITA.LI.CA) Group. Semin Oncol 41(2):252–258CrossRefPubMedPubMedCentralGoogle Scholar
  20. Chin YW, Balunas MJ, Chai HB, Kinghorn AD (2006) Drug discovery from natural sources. AAPS J 8:E239–E253CrossRefPubMedPubMedCentralGoogle Scholar
  21. Choi J, Yip-Schneider M, Albertin F, Wiesenauer C, Wang Y, Schmidt C (2008) The effect of DOXO on MEK–ERK signaling predicts its efficacy in HCC. J Surg Res 150:219–226CrossRefPubMedGoogle Scholar
  22. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1–16CrossRefPubMedPubMedCentralGoogle Scholar
  23. Cui W, Hu SX, Tang Z, Hu K (2007) In vivo effects of cyclooxygenase-2 deletion on cellular signaling in hepatocellular carcinoma xenografts in nude mice. J Cancer Mol 3:49–54Google Scholar
  24. Deepa PR, Varalakshmi P (2003) Protective effect of low molecular weight heparin on oxidative injury and cellular abnormalities in adriamycin-induced cardiac and hepatic toxicity. Chem Biol Interact 146:201–210CrossRefPubMedGoogle Scholar
  25. Deugnier Y, David V, Brissot P, Mabo P, Delamaire D, Messner M, Bourel M, Legall JY (1984) Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma. Hepatology 4:889–892CrossRefPubMedGoogle Scholar
  26. Dudka J, Gieroba R, Korga A, Burdan F, Matysiak W, Jodlowska-Jedrych B, Mandziuk S, Korobowicz E, Murias M (2012) Different effects of resveratrol on dose-related doxorubicin-induced heart and liver toxicity. Evid Based Complement Altern Med Article ID 606183:10Google Scholar
  27. El Mesallamy HO, Metwally NS, Soliman MS, Ahmed KA, Abdel Moaty MM (2011) The chemopreventive effect of Ginkgo biloba and Silybum marianum extracts on hepatocarcinogenesis in rats. Cancer Cell Int 11:38CrossRefPubMedPubMedCentralGoogle Scholar
  28. El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma, epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576CrossRefPubMedGoogle Scholar
  29. Eltamany EE, Radwan MM, Ibrahim AK, ElSohly M, Hassanean HA, Ahmed SA (2014) Antitumor metabolites from the Red Sea sponge Spheciospongia vagabunda. Planta Med 80:-PB5CrossRefGoogle Scholar
  30. Faber E (1994) Programmed cell death: necrosis versus apoptosis. Mod Pathol 7:605–609Google Scholar
  31. Fentiman IS (2012) Gamma-glutamyl transferase, risk and prognosis of cancer. Br J Cancer 106:1467–1468CrossRefPubMedPubMedCentralGoogle Scholar
  32. Fiala S, Fiala ES (1973) Activation by chemical carcinogen of gamma glutamyl transpeptidase in rat and mouse liver. J Natl Cancer Inst 51:151–158CrossRefPubMedGoogle Scholar
  33. Fiume L, Bolondi L, Busi C (2005) Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. J Hepatol 43:645–652CrossRefPubMedGoogle Scholar
  34. Friesen C, Fulda S, Debatin KM (1999) Cytotoxic drugs and the CD95 pathway. Leukemia 13:1854–1858CrossRefPubMedGoogle Scholar
  35. Gillor O, Carmeli S, Rahamim Y, Fishelson Z, Ilan M (2000) Immunolocalization of the toxin latrunculin B within the Red Sea Sponge Negombata magnifica (Demospongiae, Latrunculiidae). Mar Biotechnol 2(3):213–223CrossRefPubMedGoogle Scholar
  36. Green RM, Flamm S (2002) AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 123:1367–1384CrossRefPubMedGoogle Scholar
  37. Hamza AH, Abdulfattah HM, Mahmoud RH, Khalil WK, Ahmed HH (2015) Current concepts in pathophysiology and management of hepatocellular carcinoma. Acta Biochem Pol 62(3):573–580CrossRefGoogle Scholar
  38. Holmes EH, Hakomori SI (1982) Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2- acetylaminofluorene. J Biol Chem 257:7698–7703PubMedGoogle Scholar
  39. Hu GP, Yuan J, Sun L, She ZG, Wu JH, Lan XJ, Zhu X, Lin YC, Chen SP (2011) Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs 9:514–525CrossRefPubMedPubMedCentralGoogle Scholar
  40. Jayakumar S, Madankumar A, Asokkumar S, Raghunandhakumar S, Gokuladhas K, Kamaraj S (2012) Potential preventive effect of carvacrol against diethylnitrosamine-induced hepatocellular carcinoma in rats. Mol Cell Biochem 360:51–60CrossRefPubMedGoogle Scholar
  41. Karimov KHY, Inoyatova FKH, Mukhamedova MT (2003) Changes in some indices of the synthesis of nitric oxide during the early stages of hepatocarcinogenesis. Exp Toxicol Pathol 55(1):17–19CrossRefPubMedGoogle Scholar
  42. Kashman Y, Groweiss A, Shmueli U (1980) Latrunculin, a new 2-thiazolidinone macrolide from the marine sponge Latrunculia magnifica. Tetrahedron Lett 21:3629–3632CrossRefGoogle Scholar
  43. Kim GY, Kim WJ, Choi YH (2011) Pectenotoxin-2 from marine sponges: a potential anti-canceragent—a review. Mar Drugs 9:2176–2187CrossRefPubMedPubMedCentralGoogle Scholar
  44. Kim TH, Zhao Y, Barber MJ, Kuharsky DK, Yin XM (2000) Bid-induced cytochrome c release is mediated by a pathway independent of mitochondrial permeability transition pore and Bax. J Biol Chem 275:39474–39481CrossRefPubMedGoogle Scholar
  45. Ladd J, Lu H, Taylor AD (2009) Direct detection of carcinoembryonic antigen autoantibodies in clinical human serum samples using a surface plasmon resonance sensor. Colloids Surf B Biointerfaces 70:1–6CrossRefPubMedGoogle Scholar
  46. Laport MS, Pontes PV, Dos Santos DS, Santos-Gandelman Jde F, Muricy G, Bauwens M, Giambiagi-deMarval M, George I (2016) Antibiotic resistance genes detected in the marine sponge Petromica citrina from Brazilian coast. Braz J Microbiol 47(3):617–620CrossRefPubMedPubMedCentralGoogle Scholar
  47. Lazarevich NL (2000) Review, molecular mechanisms of alpha-fetoprotein gene expression. Biochemistry 65:117–133PubMedGoogle Scholar
  48. Lehman EM, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Shoushtari CS, Wilson ML (2008) Patterns of hepatocellular carcinoma incidence in Egypt from a population based cancer registry. Hepatol Res 38(5):465–473CrossRefPubMedGoogle Scholar
  49. Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491–501CrossRefPubMedGoogle Scholar
  50. Li N, Xiao B, Chen XB (2008) Relationship between expression of CEA, E-cadherin and liver metastasis in colorectal cancer. Chin J Clin Oncol 5:429–432CrossRefGoogle Scholar
  51. Liu JG, Zhao HJ, Liu YJ et al. (2012) Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats. J Trace Elem Med Biol 26:255–261CrossRefPubMedGoogle Scholar
  52. Lopes FCM, Rocha A, Pirraco A, Regasini LO, Silva DHS, Bolzani VS, Azevedo I, Carlos IZ, Soares R (2009) Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. BMC Complement Altern Med 9(15):1–11Google Scholar
  53. Louwrier S, Ostendorf M, Boom A, Hiemstra H, Speckamp WN (1996) Studies towards the synthesis of (+)-ptilomycalin A; Stereoselective N-acyliminium ion coupling reactions to enantiopure C-2 substituted lactams. Tetrahedron 52:2603CrossRefGoogle Scholar
  54. Lyer P, Zekri AR, Hung CW (2010) Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients. Exp Mol Pathol 88:107–111CrossRefGoogle Scholar
  55. Lytle S, Charles F, Meyer JR (2004) General zoology laboratory guide (14th edn.). McGraw-Hill, New York, NYGoogle Scholar
  56. Macnab GM, Urbanowicz JM, Kew MC (1978) Carcino-embryonic antigen in hepatocellular cancer. Br J Cancer 38:51–54CrossRefPubMedPubMedCentralGoogle Scholar
  57. Mayer AMS, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE (2010) The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 31:255–265CrossRefPubMedGoogle Scholar
  58. Motalleb G, Hanachi P, Fauziah O (2008) Effect of Berberis vulgaris fruit extract on alpha-fetoprote in gene expression and chemical carcinogen metabolizing enzymes activities in hepatocarcinogenesis rats. Iran J Cancer Prev 1:33–44Google Scholar
  59. Moustafa M, Morsi M, Hussein A, AL-Abd E, Abdel- Moneim N (2005) Evaluation of tumor necrosis factor-α (TNF-α), soluble P-selectin (sP-Selectin), gamma-glutamyl transferase(GGT), glutathione S-transferase Pi (GST-Pi) and alpha fetoprotein (AFP) in patients with hepatocellular carcinoma before and during chemotherapy. Turk J Cancer 35:5–11Google Scholar
  60. Mudit M, Khanfar M, Muralidharan A, Thomas S, Shah GV, van Soest RWM, El Sayed KA (2009) Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products. Bioorg Med Chem 17:1731CrossRefPubMedGoogle Scholar
  61. Mudit M, Behery FA, Wali VB, Sylvester PW, El Sayed KA (2010) Synthesis of fluorescent analogues of the anticancer natural products 4-hydroxyphenylmethylene hydantoin and delta-tocotrienol. Nat Prod Commun 5(10):1623–1626PubMedGoogle Scholar
  62. Müller WEG (2003) The origin of metazoan complexity: porifera as integrated animals. Integr Comp Biol 43(1):3–10CrossRefPubMedGoogle Scholar
  63. Newman DJ, Cragg GM (2004) Marine natural products and related compounds in clinical and advanced preclinical trials. J Nat Prod 67:1216–1238CrossRefPubMedGoogle Scholar
  64. Ohtani I, Kusumi T, Kakisawa H, Kashman Y, Hirsh S (1992) Structure and chemical properties of ptilomycalin A. J Am Chem Soc 114:8472–8479CrossRefGoogle Scholar
  65. Pal S, Sengupta Sadhu A, Patra S, Mukherjea KK (2008) Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models. J Exp Clin Cancer Res 27:68CrossRefPubMedPubMedCentralGoogle Scholar
  66. Persijn JP, van der Slik W (1976) A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem 14:421–427PubMedGoogle Scholar
  67. Rady H (2014) Sponge mesohyl induces anti-proliferation activity and cell cycle arrest in colon cancer in-vitro. Res J Pharm Biol Chem Sci 5(6):1070–1076Google Scholar
  68. Rady HM, Hassan AZ, Salem SM, Mohamed TK, Esmaiel NN, Ez- El-Arab MA, Ibrahim MA, Fouda FK (2016) Induction of apoptosis and cell cycle arrest by Negombata magnifica sponge in hepatocellular carcinoma. Med Chem Res 1:1–24Google Scholar
  69. Ray SD (2003) Oxidative stress orchestrates both apoptosis & necrosis in vivo: a new perspective from molecular toxicology. In: Galaris D (ed) Proc. of Meeting of the Society of Free Radical Research, Medimond Int. Publishers, Italy, pp 45–53Google Scholar
  70. Reitman S, Frankel S (1957) A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Path 28:56–63CrossRefPubMedGoogle Scholar
  71. Saad SY, Najja TA, Al-Rikabi AC (2001) The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol Res 43:211–218CrossRefPubMedGoogle Scholar
  72. Schermer (1967) The blood morphology of laboratory animals, 3rd edn. F.A. Davi, Philadelphia, p 42Google Scholar
  73. Sell S, Becker F, Leffert HL (1983) α-Fetoprotein as a marker for early events and carcinoma development during chemical hepatocarcinogenesis. Environ Sci Res 29:271–293Google Scholar
  74. Seufi A, Safinz S, Ibrahim S (2009) Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity, molecular and histological evidences. J Exp Clin Canc Res 28:80–86CrossRefGoogle Scholar
  75. Shah GV, Muralidharan A, Thomas S, Gokulgandhi M, Mudit M, Khanfar M, El Sayed K (2009) Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis. Mol Cancer Ther 8:509CrossRefPubMedPubMedCentralGoogle Scholar
  76. Shahat AA, Al said MS, Kotob SE, Ahmed HH (2015) Significance of Rumex Vesicarius as anticancer remedy against hepatocellular carcinoma: a proposal-based on experimental animal studies. Asian Pac J Cancer Prev 16(10):4303–4310CrossRefPubMedGoogle Scholar
  77. Sivaramakrishnan V, Shilpa PN, Praveen-Kumar D, Niranjali-Devarai S (2007) Attenuation of N-nitrosodiethylamine induced hepatocellular carcinogenesis by a novel flavonol-Morin. Chem Biol Interact 171:78–79Google Scholar
  78. Sorek H, Rudi A, Gueta S, Reyes F, Martin MJ, Aknin M, Gaydou E, Vacelet J, Kashman Y (2006) Netamines A-G: seven new tricyclic guanidine alkaloids from the marine sponge Biemna laboutei. Tetrahedron 62:8838–8843CrossRefGoogle Scholar
  79. Srivatanakul P, Sriplung H, Deerasamee S (2007) Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 5:118–125Google Scholar
  80. Stan AC, Radu DL, Casares S, Bona CA, Brumeanu TD (1999) Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen. Cancer Res 59:115–121PubMedGoogle Scholar
  81. Sun B, Karin M (2008) NF-κB signaling, liver disease and hepatoprotective agents. Oncogene 27:6228–6244CrossRefPubMedGoogle Scholar
  82. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC (2008) Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. J Am Med Assoc 299:53CrossRefGoogle Scholar
  83. Thomas P, Hems DA (1975) The hepatic clearance of circulating native and asialo carcinoembryonic antigen by the rat. Biochem Biophys Res Comm 67:1205–1209CrossRefPubMedGoogle Scholar
  84. Trivedi NP, Rawal UM (2001) Gamma-glutamyl transpeptidase gene organization and expression: a comparative analysis in rat, mouse, pig and human species. Indian J Exp Biol 39:41–46PubMedGoogle Scholar
  85. Vanisree AJ, Shyamaladevi CS (1998) Effect of therapeutic strategy established by N-acetyl cystine and vitamin C on the activities of tumour marker enzymes in vitro. Ind J Pharmacol 31:275–278Google Scholar
  86. Verna L, Whysner J, Williams GM (1996) N-Nitrodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity and tumor initiation. Pharmacol Ther 71:57–81CrossRefPubMedGoogle Scholar
  87. Vischer P, Reutter W (1978) Specific alterations of fucoprotein biosynthesis in the plasma membrane of Morris hepatoma 7777. Eur J Biochem 84:363–368CrossRefPubMedGoogle Scholar
  88. Walter M, Gerade H (1970) Ultramicromethod for determination of conjugated and total bilirubin in serum or plasma. Microchem J 15:231–238CrossRefGoogle Scholar
  89. Wang Y, Shen Y (2013) Unresectable hepatocellular carcinoma treated withtransarterial chemoembolization: clinical data from a single teaching hospital. Int J Clin Exp Med 6(5):367–371PubMedPubMedCentralGoogle Scholar
  90. World Health Organization (2015) Cancer. World Health Organization. Lyon/GenevaGoogle Scholar
  91. Yao DF, Dong ZZ, Yao M (2007) Specific markers in hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 6:241–247PubMedGoogle Scholar
  92. Zhou L, Liu J, Luo F (2006) Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 12(8):1175–1181CrossRefPubMedPubMedCentralGoogle Scholar
  93. Zielke K, Okada S, O’Brien JS (1972) Fucosidosis: diagnosis by serum assay of α-L- fucosidase. Transl Res 79(1):164–169Google Scholar
  94. Zimmer R, Thomas P (2001) Mutations in the carcinoembryonic antigen gene in colorectal cancer patients: implications on liver metastasis. Cancer Res 61:2822–2826PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Hanaa H. Ahmed
    • 1
  • Hanaa M. Rady
    • 2
  • Soheir E. Kotob
    • 1
  1. 1.Hormones DepartmentNational Research CentreGizaEgypt
  2. 2.Chemistry of Natural Compounds DepartmentNational Research CentreGizaEgypt

Personalised recommendations